[Federal Register Volume 89, Number 187 (Thursday, September 26, 2024)]
[Notices]
[Pages 78902-78903]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-22069]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--The Customer Experience Hub

    Notice is hereby given that, on July 3, 2024, pursuant to section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), The Customer Experience Hub (``CX 
Hub'') has filed written notifications simultaneously with the Attorney 
General and the Federal Trade Commission disclosing changes in its 
membership. The notifications were filed for the purpose of extending 
the Act's provisions limiting the recovery of antitrust plaintiffs to 
actual damages under specified circumstances. Specifically, Advanced 
Functional Fabrics of America, Inc., Cambridge, MA; Alacura Medical 
Transport Management, Inc., Dallas, TX; Amazon Web Services, Inc., 
Seattle, WA; AMPEL LLC dba AMPEL BioSolutions LLC, Charlottesville, VA; 
Aptima, Inc., Woburn, MA; Avsana Labs, Inc., Dallas, TX; Axiom Space, 
Inc., Houston, TX; Be Well Texas, San Antonio, TX; BetterAge, 
Sunnyside, NY; Bexar County Hospital District dba University Health 
System, San Antonio, TX; BioCytics, Inc., Huntersville, NC; Boyd 
Biomedical, Inc., Lee, MA;

[[Page 78903]]

Carolina BioOncology Institute PLLC, Huntersville, NC; Clinicals Global 
Pty Ltd., Fortitude Valley, AUSTRALIA; Cure Experience Service LLC, New 
York, NY; DesignPlex Biomedical LLC, Fort Worth, TX; Detroit 
Association of Black Organizations, Inc. (DABO), Detroit, MI; 
DiversiTrials, Florence, KY; Dynocardia, Inc., Cambridge, MA; Echo 
Investment Capital, Oklahoma City, OK; Elarex, Inc., Burlington, 
CANADA; Emagine Solutions Technology LLC, Tucson, AZ; Essex Management 
LLC, Rockville, MD; Esvyda!, Inc., Campbell, CA; Eztia Corp., Diamond 
Bar, CA; Focused Ultrasound Foundation, Charlottesville, VA; Galen 
Data, Inc., Houston, TX; GE Healthcare Technology & Innovation Center, 
Niskayuna, NY; Gryphon Scientific LLC, Takoma Park, MD; IA 
Collaborative Management Services LLC, Chicago, IL; Implementation 
Science Center for Cancer Control Equity (ISCCCE), Boston, MA; InnoTech 
Precision Medicine, Inc., Lowell, MA; Inter Astra Institute, McLean, 
VA; Maternal Newborn Health Innovations, PBC (MNHI), Parsippany, NJ; 
Maximus, Inc., McLean, VA; MediMergent LLC, Rockville, MD; Metronomic, 
Inc., Chantilly, VA; Mid-Atlantic Permanente Medical Group, P.C., 
Rockville, MD; MitoChem Therapeutics, Inc., Charleston, SC; Namida Lab, 
Inc., Fayetteville, AR; National Health Council, Inc., Washington, DC; 
NKILT Therapeutics, Inc., Springfield, NJ; Northeastern University, 
Boston, MA; OnKai, Inc., Boca Raton, FL; Parallax Advanced Research 
Corp., Beavercreek, OH; Pediatric Moonshot, Marina del Rey, CA; Proov, 
Erie, CO; Quorum Innovations LLC, Sarasota, FL; SANO Healthcare 
Consultants LLC, Ontario, CA; SEQSTER PDM, Inc., San Diego, CA; Spring 
Discovery, Inc., San Carlos, CA; Starling Medical, Inc., Houston, TX; 
SubjectWell, Inc., Austin, TX; Synthesize Consulting Group, Woodbridge, 
CANADA; Texas A&M University-Corpus Christi, Corpus Christi, TX; The 
Emmes Company LLC, Rockville, MD; The Termeer Foundation, Boston, MA; 
The University of Texas Health Science Center at Tyler, Tyler, TX; 
Touch4Life, Clarksville, MD; Triple Ring Technologies, Inc., Newark, 
CA; University of Connecticut Health Center, Farmington, CT; University 
of Illinois, Chicago, IL; University of Illinois Urbana-Champaign, 
Urbana, IL; University of Missouri System, Columbia, MO; University of 
Texas Health Science Center at Houston, Houston, TX; University of 
Texas Medical Branch at Galveston, Galveston, TX; University of Texas 
Southwestern Medical Center, Dallas, TX; Washington Global Health 
Alliance, Redmond, WA; Washington University in St. Louis, St. Louis, 
MO; and Wiliam Marsh Rice University, Houston, TX, have been added as 
parties to this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and CX Hub intends to file additional 
written notifications disclosing all changes in membership.
    On January 11, 2024, CX Hub filed its original notification 
pursuant to section 6(a) of the Act. The Department of Justice 
published a notice in the Federal Register pursuant to section 6(b) of 
the Act on April 16, 2024 (89 FR 26929).
    The last notification was filed with the Department on April 17, 
2024. A notice was published in the Federal Register pursuant to 
section 6(b) of the Act on June 21, 2024 (89 FR 52093).

Suzanne Morris,
Deputy Director Civil Enforcement Operations, Antitrust Division.
[FR Doc. 2024-22069 Filed 9-25-24; 8:45 am]
BILLING CODE P